This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Click to download for more information on PD-L1 Testing and CPS Interpretation in Oesophageal Cancer

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]

Download this leaflet for more information on PD-L1 Testing and CPS Scoring in Oesophageal Cancer.

Abbreviations: CPS, combined positive score

More information about KEYTRUDA® (pembrolizumab) in locally advanced unresectable or metastatic oesophageal cancer

Supporting documentation

Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website

GB-PDO-01684 | Date of Preparation: October 2021